Clinical trialNCT03786471CompletedInterventional

D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care

SponsorUniversity of California, Los AngelesEnrollment2,176Dementia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

D-CARE: The Dementia Care Study This pragmatic randomized clinical trial of 2150 persons with dementia and their caregivers, at four diverse clinical trial sites in the United States, compares the effectiveness and cost-effectiveness of 18 months of health systems-based dementia care provided by a Dementia Care Specialist (nurse practitioner or physician assistant) who works within the heath system versus community-based dementia care provided by a Care Consultant (social worker, nurse, or therapist) who works at a Community-Based Organization (CBO). The trial will also compare the effectiveness and cost-effectiveness of both models versus usual care.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Alan Stevens, PhD
Baylor Scott and White Health
Principal Investigator
clinicaltrials.gov ↗
Christopher Callahan, MD
Indiana University
Study Chair
clinicaltrials.gov ↗
David Bass, PhD
Benjamin Rose Institute on Aging
Principal Investigator
clinicaltrials.gov ↗
David Reuben, MD
University of California, Los Angeles
Principal Investigator
clinicaltrials.gov ↗
Elena Volpi, MD, PhD
The University of Texas Health Science Center at San Antonio
Principal Investigator
clinicaltrials.gov ↗
Jeffrey Williamson, MD
Wake Forest University Health Sciences
Principal Investigator
clinicaltrials.gov ↗
Jenny Summapund, MA
University of California, Los Angeles
Study Director
clinicaltrials.gov ↗
Katie Maslow, MSW
Gerontological Society of America
Study Chair
clinicaltrials.gov ↗
Lee Jennings, MD
University of Oklohoma
Principal Investigator
clinicaltrials.gov ↗
Maya Lichtenstein, MD
Geisinger Clinic
Principal Investigator
clinicaltrials.gov ↗
Peter Peduzzi, PhD
Yale University
Principal Investigator
clinicaltrials.gov ↗
Thomas Gill, MD
Yale University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Geisinger Health
Wilkes-Barre, Pennsylvania, United States
University of Texas Medical Branch
Galveston, Texas, United States
Baylor Scott & White
Temple, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Jun 2019
Primary completion: 21 Aug 2023
Completion: 21 Aug 2023
Last update posted: 30 Jan 2025
Registered enrollment: 2,176
Registry id: NCT03786471

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.